Comparison 4. Blue light versus white light—subgroup analysis of 5‐ALA versus HAL (post hoc).
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
4.1 Time to disease recurrence | 15 | 2994 | Hazard Ratio (IV, Random, 95% CI) | 0.66 [0.54, 0.81] |
4.1.1 5‐ALA | 6 | 1430 | Hazard Ratio (IV, Random, 95% CI) | 0.76 [0.57, 1.00] |
4.1.2 HAL | 9 | 1564 | Hazard Ratio (IV, Random, 95% CI) | 0.60 [0.45, 0.78] |
4.2 Time to disease progression | 9 | 2200 | Hazard Ratio (IV, Random, 95% CI) | 0.77 [0.63, 0.96] |
4.2.1 5‐ALA | 5 | 1239 | Hazard Ratio (IV, Random, 95% CI) | 0.72 [0.47, 1.11] |
4.2.2 HAL | 4 | 961 | Hazard Ratio (IV, Random, 95% CI) | 0.69 [0.48, 0.98] |